Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05375903
Title A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors UroGen Pharma Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ESP

Facility Status City State Zip Country Details
Arkansas Urology Little Rock Arkansas 72211 United States Details
UCLA - University of California Los Angeles California 90095 United States Details
Florida Urology Partners, LLC Tampa Florida 33615 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Manhattan Medical Research New York New York 10016 United States Details
Clinical Research Solutions Middleburg Heights Ohio 44130 United States Details
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033 United States Details
I.R.C.C.S. Ospedale San Raffaele Milan Italy Details
National Tumor Institute Fondazione G. Pascale Naples Italy Details
Istituto Oncologico Veneto Padova Italy Details
NEXT Oncology IOB- Hospital Quironsalud Barcelona Barcelona 08023 Spain Details
Hospital Clinic de Barcelona Instituto Clinic de Nefrologia y Urologia (ICNU) Barcelona 08036 Spain Details
NEXT Oncology- Hospital Quironsalud Mardrid Madrid 28223 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field